ASO Author Reflections: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9. - Yamanaka M; Hayashi M; Kodera Y (Annals of surgical oncology, 2022)